TMCO1 and glioma: Furthermore, in glioma cell lines and ovarian granulosa cells, TMCO1 knockdown is associated with decreased levels of BCL-2 [15, 45], potentially affecting the BH3 profile and therefore sensitivity to BCL-2 inhibitors used in our study.